Sign in
4

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0001567619-23-000326

Options or other derivatives

  • Chief Operating Officer acquired 106,648 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Floyd Robert Michael · Chief Operating Officer

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2022-12-31 Grant or award : show line 1 in the form Restricted Stock Units +10,851 344,531 D
2023-01-01 Grant or award : show line 2 in the form Restricted Stock Units +55,107 399,638 D
2023-01-01 Grant or award : show line 3 in the form Restricted Stock Units +40,690 440,328 D
Loading xslF345X03/doc1.xml…